{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:10:04Z","timestamp":1790385004892,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11060-020-03612-7","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T17:22:09Z","timestamp":1605806529000},"page":"215-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update"],"prefix":"10.1007","volume":"150","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3671-2638","authenticated-orcid":false,"given":"Mateo","family":"Ziu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty Y. S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Ryken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"3612_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ijrobp.2014.07.014","volume":"90","author":"SN Badiyan","year":"2014","unstructured":"Badiyan SN, Markovina S, Simpson JR et al (2014) Radiation therapy dose escalation for glioblastoma multiforme in the era of temozolomide. Int J Radiat Oncol Biol Phys 90:877\u2013885. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.07.014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3612_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11060-008-9617-2","volume":"89","author":"J Buatti","year":"2008","unstructured":"Buatti J, Ryken TC, Smith MC et al (2008) Radiation therapy of pathologically confirmed newly diagnosed glioblastoma in adults. J Neurooncol 89:313\u2013337. https:\/\/doi.org\/10.1007\/s11060-008-9617-2","journal-title":"J Neurooncol"},{"key":"3612_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"3612_CR4","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ijrobp.2014.07.046","volume":"90","author":"CG Rusthoven","year":"2014","unstructured":"Rusthoven CG, Carlson JA, Waxweiler TV et al (2014) The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population. Int J Radiat Oncol Biol Phys 90:894\u2013902. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.07.046","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3612_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1158\/1078-0432.CCR-11-2073","volume":"18","author":"CI Tsien","year":"2012","unstructured":"Tsien CI, Brown D, Normolle D et al (2012) Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma. Clin Cancer Res 18:273\u2013279. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2073","journal-title":"Clin Cancer Res"},{"key":"3612_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijrobp.2009.10.048","volume":"79","author":"MW McDonald","year":"2011","unstructured":"McDonald MW, Shu H-KG, Curran WJ, Crocker IR (2011) Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma. Int J Radiat Oncol Biol Phys 79:130\u2013136. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.10.048","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3612_CR7","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3346\/jkms.2013.28.8.1233","volume":"28","author":"TG Kim","year":"2013","unstructured":"Kim TG, Lim DH (2013) Interfractional variation of radiation target and adaptive radiotherapy for totally resected glioblastoma. J Korean Med Sci 28:1233\u20131237. https:\/\/doi.org\/10.3346\/jkms.2013.28.8.1233","journal-title":"J Korean Med Sci"},{"key":"3612_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ijrobp.2013.01.009","volume":"86","author":"P Lee","year":"2013","unstructured":"Lee P, Eppinga W, Lagerwaard F et al (2013) Evaluation of high ipsilateral subventricular zone radiation therapy dose in glioblastoma: a pooled analysis. Int J Radiat Oncol Biol Phys 86:609\u2013615. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.01.009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3612_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s11060-014-1424-3","volume":"118","author":"O Elicin","year":"2014","unstructured":"Elicin O, Inac E, Uzel EK et al (2014) Relationship between survival and increased radiation dose to subventricular zone in glioblastoma is controversial. J Neurooncol 118:413\u2013419. https:\/\/doi.org\/10.1007\/s11060-014-1424-3","journal-title":"J Neurooncol"},{"key":"3612_CR10","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ijrobp.2013.02.014","volume":"86","author":"L Chen","year":"2013","unstructured":"Chen L, Guerrero-Cazares H, Ye X et al (2013) Increased subventricular zone radiation dose correlates with survival in glioblastoma patients after gross total resection. Int J Radiat Oncol Biol Phys 86:616\u2013622. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.02.014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3612_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11060-012-0887-3","volume":"109","author":"T Gupta","year":"2012","unstructured":"Gupta T, Nair V, Paul SN et al (2012) Can irradiation of potential cancer stem-cell niche in the subventricular zone influence survival in patients with newly diagnosed glioblastoma? J Neurooncol 109:195\u2013203. https:\/\/doi.org\/10.1007\/s11060-012-0887-3","journal-title":"J Neurooncol"},{"key":"3612_CR12","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s12094-017-1659-5","volume":"19","author":"P Foro Arnalot","year":"2017","unstructured":"Foro Arnalot P, Pera O, Rodriguez N et al (2017) Influence of incidental radiation dose in the subventricular zone on survival in patients with glioblastoma multiforme treated with surgery, radiotherapy, and temozolomide. Clin Transl Oncol 19:1225\u20131231. https:\/\/doi.org\/10.1007\/s12094-017-1659-5","journal-title":"Clin Transl Oncol"},{"key":"3612_CR13","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.7812\/TPP\/14-083","volume":"356","author":"F Keime-Guibert","year":"2007","unstructured":"Keime-Guibert F, Chinot O, Taillandier L (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527\u20131535. https:\/\/doi.org\/10.7812\/TPP\/14-083","journal-title":"N Engl J Med"},{"key":"3612_CR14","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3171\/2015.4.JNS142200","volume":"124","author":"R Babu","year":"2016","unstructured":"Babu R, Komisarow JM, Agarwal VJ et al (2016) Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival. J Neurosurg 124:998\u20131007. https:\/\/doi.org\/10.3171\/2015.4.JNS142200","journal-title":"J Neurosurg"},{"key":"3612_CR15","doi-asserted-by":"publisher","first-page":"e0127202","DOI":"10.1371\/journal.pone.0127202","volume":"10","author":"KG Abdullah","year":"2015","unstructured":"Abdullah KG, Ramayya A, Thawani JP et al (2015) Factors associated with increased survival after surgical resection of glioblastoma in octogenarians. PLoS ONE 10:e0127202. https:\/\/doi.org\/10.1371\/journal.pone.0127202","journal-title":"PLoS ONE"},{"key":"3612_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s00066-011-0026-7","volume":"188","author":"M Niyazi","year":"2012","unstructured":"Niyazi M, Schwarz SB, Suchorska B, Belka C (2012) Radiotherapy with and without temozolomide in elderly patients with glioblastoma. Strahlenther Onkol 188:154\u2013159. https:\/\/doi.org\/10.1007\/s00066-011-0026-7","journal-title":"Strahlenther Onkol"},{"key":"3612_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ijrobp.2010.04.033","volume":"81","author":"J Scott","year":"2011","unstructured":"Scott J, Tsai Y-Y, Chinnaiyan P, Yu H-HM (2011) Effectiveness of radiotherapy for elderly patients with glioblastoma. Int J Radiat Oncol Biol Phys 81:206\u2013210. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.04.033","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3612_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.radonc.2005.03.004","volume":"75","author":"CAM Marijnen","year":"2005","unstructured":"Marijnen CAM, van den Berg SMP, van Duinen SG et al (2005) Radiotherapy is effective in patients with glioblastoma multiforme with a limited prognosis and in patients above 70 years of age: a retrospective single institution analysis. Radiother Oncol 75:210\u2013216. https:\/\/doi.org\/10.1016\/j.radonc.2005.03.004","journal-title":"Radiother Oncol"},{"key":"3612_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.ijrobp.2007.07.2368","volume":"70","author":"SE Combs","year":"2008","unstructured":"Combs SE, Wagner J, Bischof M et al (2008) Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Intl J Radiat Oncol Biol Phys 70:987\u2013992. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.07.2368","journal-title":"Intl J Radiat Oncol Biol Phys"},{"key":"3612_CR20","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1200\/JCO.2015.62.6606","volume":"33","author":"W Roa","year":"2015","unstructured":"Roa W, Kepka L, Kumar N, Sinaika V (2015) International Atomic Energy Agency randomized phase III study of radiation therapy in elderly and\/or frail patients with newly diagnosed glioblastoma multiforme. J Clin Oncol 33:4145\u20134150. https:\/\/doi.org\/10.1200\/JCO.2015.62.6606","journal-title":"J Clin Oncol"},{"key":"3612_CR21","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","volume":"13","author":"A Malmstr\u00f6m","year":"2012","unstructured":"Malmstr\u00f6m A, Gr\u00f8nberg BH, Marosi C et al (2012) Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. Lancet Oncol 13:916\u2013926. https:\/\/doi.org\/10.1016\/S1470-2045(12)70265-6","journal-title":"Lancet Oncol"},{"key":"3612_CR22","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ijrobp.2013.02.013","volume":"86","author":"G Minniti","year":"2013","unstructured":"Minniti G, Scaringi C, Baldoni A et al (2013) Health-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomide. Int J Radiat Oncol Biol Phys 86:285\u2013291. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.02.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3612_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ijrobp.2014.09.013","volume":"91","author":"G Minniti","year":"2015","unstructured":"Minniti G, Scaringi C, Lanzetta G et al (2015) Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis. Int J Radiat Oncol Biol Phys 91:109\u2013115. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.09.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3612_CR24","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s13014-017-0929-2","volume":"12","author":"J Biau","year":"2017","unstructured":"Biau J, Chautard E, De Schlichting E et al (2017) Radiotherapy plus temozolomide in elderly patients with glioblastoma: a \u201creal-life\u201d report. Radiat Oncol 12:197. https:\/\/doi.org\/10.1186\/s13014-017-0929-2","journal-title":"Radiat Oncol"},{"key":"3612_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s11060-016-2182-1","volume":"129","author":"S Bracci","year":"2016","unstructured":"Bracci S, Laigle-Donadey F, Hitchcock K et al (2016) Role of irradiation for patients over 80 years old with glioblastoma: a retrospective cohort study. J Neurooncol 129:347\u2013353. https:\/\/doi.org\/10.1007\/s11060-016-2182-1","journal-title":"J Neurooncol"},{"key":"3612_CR26","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.prro.2015.12.001","volume":"6","author":"TJC Wang","year":"2016","unstructured":"Wang TJC, Wu C-C, Jani A et al (2016) Hypofractionated radiation therapy versus standard fractionated radiation therapy with concurrent temozolomide in elderly patients with newly diagnosed glioblastoma. Pract Radiat Oncol 6:306\u2013314. https:\/\/doi.org\/10.1016\/j.prro.2015.12.001","journal-title":"Pract Radiat Oncol"},{"key":"3612_CR27","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s00066-013-0346-x","volume":"189","author":"L Fariselli","year":"2013","unstructured":"Fariselli L, Pinzi V, Milanesi I et al (2013) Short-course radiotherapy in elderly patients with glioblsastoma: feasibility and efficacy of results from a single centre. Strahlenther Onkol 189:456\u2013461. https:\/\/doi.org\/10.1007\/s00066-013-0346-x","journal-title":"Strahlenther Onkol"},{"key":"3612_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijrobp.2011.06.1992","volume":"83","author":"G Minniti","year":"2012","unstructured":"Minniti G, Lanzetta G, Scaringi C et al (2012) Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Int J Radiat Oncol Biol Phys 83:93\u201399. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.06.1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3612_CR29","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.canrad.2008.05.007","volume":"12","author":"A Idbaih","year":"2008","unstructured":"Idbaih A, Taillibert S, Simon JM et al (2008) Short course of radiation therapy in elderly patients with glioblastoma multiforme. Cancer Radiother 12:788\u2013792. https:\/\/doi.org\/10.1016\/j.canrad.2008.05.007","journal-title":"Cancer Radiother"},{"key":"3612_CR30","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.ijrobp.2017.03.037","volume":"98","author":"D Guedes de Castro","year":"2017","unstructured":"Guedes de Castro D, Matiello J, Roa W et al (2017) Survival outcomes with short-course radiation therapy in elderly patients with glioblastoma: data from a randomized phase 3 trial. Int J Radiat Oncol Biol Phys 98:931\u2013938. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.03.037","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3612_CR31","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/cam4.1070","volume":"6","author":"KS Mak","year":"2017","unstructured":"Mak KS, Agarwal A, Qureshi MM, Truong MT (2017) Hypofractionated short-course radiotherapy in elderly patients with glioblastoma multiforme: an analysis of the National Cancer Database. Cancer Med 6:1192\u20131200. https:\/\/doi.org\/10.1002\/cam4.1070","journal-title":"Cancer Med"},{"key":"3612_CR32","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1186\/s12885-015-1545-x","volume":"15","author":"S Adeberg","year":"2015","unstructured":"Adeberg S, Bostel T, Harrabi S et al (2015) Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma. BMC Cancer 15:558. https:\/\/doi.org\/10.1186\/s12885-015-1545-x","journal-title":"BMC Cancer"},{"key":"3612_CR33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1227\/NEU.0000000000000766","volume":"77","author":"SJ Han","year":"2015","unstructured":"Han SJ, Rutledge WC, Molinaro AM et al (2015) The effect of timing of concurrent chemoradiation in patients with newly diagnosed glioblastoma. Neurosurgery 77:248\u2013253. https:\/\/doi.org\/10.1227\/NEU.0000000000000766","journal-title":"Neurosurgery"},{"key":"3612_CR34","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3171\/2014.9.JNS14193","volume":"122","author":"MZ Sun","year":"2015","unstructured":"Sun MZ, Oh T, Ivan ME et al (2015) Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma. J Neurosurg 122:1144\u20131150. https:\/\/doi.org\/10.3171\/2014.9.JNS14193","journal-title":"J Neurosurg"},{"key":"3612_CR35","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11060-013-1302-4","volume":"116","author":"DE Spratt","year":"2014","unstructured":"Spratt DE, Folkert M, Zumsteg ZS et al (2014) Temporal relationship of post-operative radiotherapy with temozolomide and oncologic outcome for glioblastoma. J Neurooncol 116:357\u2013363. https:\/\/doi.org\/10.1007\/s11060-013-1302-4","journal-title":"J Neurooncol"},{"key":"3612_CR36","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1007\/s12094-012-0916-x","volume":"15","author":"I Valduvieco","year":"2013","unstructured":"Valduvieco I, Verger E, Bruna J et al (2013) Impact of radiotherapy delay on survival in glioblastoma. Clin Transl Oncol 15:278\u2013282. https:\/\/doi.org\/10.1007\/s12094-012-0916-x","journal-title":"Clin Transl Oncol"},{"key":"3612_CR37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/neuonc\/nop004","volume":"12","author":"R Lai","year":"2010","unstructured":"Lai R, Hershman DL, Doan T, Neugut AI (2010) The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme. Neuro-oncology 12:190\u2013198. https:\/\/doi.org\/10.1093\/neuonc\/nop004","journal-title":"Neuro-oncology"},{"key":"3612_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clineuro.2016.10.012","volume":"151","author":"DM Randolph","year":"2016","unstructured":"Randolph DM, McTyre ER, Paulsson AK et al (2016) Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma. Clin Neurol Neurosurg 151:73\u201378. https:\/\/doi.org\/10.1016\/j.clineuro.2016.10.012","journal-title":"Clin Neurol Neurosurg"},{"key":"3612_CR39","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1227\/NEU.0000000000001036","volume":"78","author":"TJC Wang","year":"2016","unstructured":"Wang TJC, Jani A, Estrada JP et al (2016) Timing of adjuvant radiotherapy in glioblastoma patients: a single-institution experience with more than 400 patients. Neurosurgery 78:676\u2013682. https:\/\/doi.org\/10.1227\/NEU.0000000000001036","journal-title":"Neurosurgery"},{"key":"3612_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11060-012-0883-7","volume":"109","author":"G Noel","year":"2012","unstructured":"Noel G, Huchet A, Feuvret L et al (2012) Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy. J Neurooncol 109:167\u2013175. https:\/\/doi.org\/10.1007\/s11060-012-0883-7","journal-title":"J Neurooncol"},{"key":"3612_CR41","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1200\/JCO.2008.18.9035","volume":"27","author":"DT Blumenthal","year":"2009","unstructured":"Blumenthal DT, Won M, Mehta MP et al (2009) Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database. J Clin Oncol 27:733\u2013739. https:\/\/doi.org\/10.1200\/JCO.2008.18.9035","journal-title":"J Clin Oncol"},{"key":"3612_CR42","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.3760\/cma.j.issn.0366-6999.20130218","volume":"126","author":"Y-D Chen","year":"2013","unstructured":"Chen Y-D, Feng J, Fang T et al (2013) Effect of intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy on clinical outcomes in patients with glioblastoma multiforme. Chin Med J 126:2320\u20132324. https:\/\/doi.org\/10.3760\/cma.j.issn.0366-6999.20130218","journal-title":"Chin Med J"},{"key":"3612_CR43","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1200\/JCO.1992.10.2.264","volume":"10","author":"TE Goffman","year":"1992","unstructured":"Goffman TE, Dachowski LJ, Bobo H et al (1992) Long-term follow-up on National Cancer Institute Phase I\/II study of glioblastoma multiforme treated with iododeoxyuridine and hyperfractionated irradiation. J Clin Oncol 10:264\u2013268","journal-title":"J Clin Oncol"},{"key":"3612_CR44","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/neuonc\/noq008","volume":"12","author":"P Beauchesne","year":"2010","unstructured":"Beauchesne P, Bernier V, Carnin C et al (2010) Prolonged survival for patients with newly diagnosed, inoperable glioblastoma with 3-times daily ultrafractionated radiation therapy. Neuro-oncology 12:595\u2013602. https:\/\/doi.org\/10.1093\/neuonc\/noq008","journal-title":"Neuro-oncology"},{"key":"3612_CR45","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/ijc.29898","volume":"138","author":"P Beauchesne","year":"2016","unstructured":"Beauchesne P, Quillien V, Faure G et al (2016) A concurrent ultra-fractionated radiation therapy and temozolomide treatment: a promising therapy for newly diagnosed, inoperable glioblastoma. Int J Cancer 138:1538\u20131544. https:\/\/doi.org\/10.1002\/ijc.29898","journal-title":"Int J Cancer"},{"key":"3612_CR46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.radonc.2017.12.006","volume":"127","author":"P Navarria","year":"2018","unstructured":"Navarria P, Pessina F, Franzese C et al (2018) Hypofractionated radiation therapy (HFRT) versus conventional fractionated radiation therapy (CRT) for newly diagnosed glioblastoma patients. A propensity score matched analysis. Radiother Oncol 127:108\u2013113. https:\/\/doi.org\/10.1016\/j.radonc.2017.12.006","journal-title":"Radiother Oncol"},{"key":"3612_CR47","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13014-015-0396-6","volume":"10","author":"M Azoulay","year":"2015","unstructured":"Azoulay M, Santos F, Souhami L et al (2015) Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution. Radiat Oncol 10:106. https:\/\/doi.org\/10.1186\/s13014-015-0396-6","journal-title":"Radiat Oncol"},{"key":"3612_CR48","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.ijrobp.2015.01.017","volume":"92","author":"ND Arvold","year":"2015","unstructured":"Arvold ND, Tanguturi SK, Aizer AA et al (2015) Hypofractionated versus standard radiation therapy with or without temozolomide for older glioblastoma patients. Int J Radiat Oncol Biol Phys 92:384\u2013389. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.01.017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3612_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10147-014-0690-6","volume":"20","author":"YJ Lim","year":"2015","unstructured":"Lim YJ, Kim IH, Han TJ et al (2015) Hypofractionated chemoradiotherapy with temozolomide as a treatment option for glioblastoma patients with poor prognostic features. Int J Clin Oncol 20:21\u201328. https:\/\/doi.org\/10.1007\/s10147-014-0690-6","journal-title":"Int J Clin Oncol"},{"key":"3612_CR50","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ijrobp.2013.12.011","volume":"88","author":"T Iuchi","year":"2014","unstructured":"Iuchi T, Hatano K, Kodama T et al (2014) Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys 88:793\u2013800. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.12.011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3612_CR51","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.clineuro.2013.02.001","volume":"115","author":"P Ciammella","year":"2013","unstructured":"Ciammella P, Galeandro M, D\u2019Abbiero N et al (2013) Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience. Clin Neurol Neurosurg 115:1609\u20131614. https:\/\/doi.org\/10.1016\/j.clineuro.2013.02.001","journal-title":"Clin Neurol Neurosurg"},{"key":"3612_CR52","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ijrobp.2012.01.035","volume":"84","author":"K Reddy","year":"2012","unstructured":"Reddy K, Damek D, Gaspar LE et al (2012) Phase II trial of hypofractionated IMRT with temozolomide for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys 84:655\u2013660. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.01.035","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3612_CR53","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11060-010-0306-6","volume":"102","author":"M Terasaki","year":"2011","unstructured":"Terasaki M, Eto T, Nakashima S et al (2011) A pilot study of hypofractionated radiation therapy with temozolomide for adults with glioblastoma multiforme. J Neurooncol 102:247\u2013253. https:\/\/doi.org\/10.1007\/s11060-010-0306-6","journal-title":"J Neurooncol"},{"key":"3612_CR54","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","volume":"22","author":"W Roa","year":"2004","unstructured":"Roa W (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol 22:1583\u20131588. https:\/\/doi.org\/10.1200\/JCO.2004.06.082","journal-title":"J Clin Oncol"},{"key":"3612_CR55","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11060-013-1139-x","volume":"113","author":"JD Waters","year":"2013","unstructured":"Waters JD, Rose B, Gonda DD et al (2013) Immediate post-operative brachytherapy prior to irradiation and temozolomide for newly diagnosed glioblastoma. J Neurooncol 113:467\u2013477. https:\/\/doi.org\/10.1007\/s11060-013-1139-x","journal-title":"J Neurooncol"},{"key":"3612_CR56","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1259\/bjr\/29022270","volume":"84","author":"M Matsuda","year":"2011","unstructured":"Matsuda M, Yamamoto T, Ishikawa E et al (2011) Prognostic factors in glioblastoma multiforme patients receiving high-dose particle radiotherapy or conventional radiotherapy. Br J Radiol 84:54\u201360. https:\/\/doi.org\/10.1259\/bjr\/29022270","journal-title":"Br J Radiol"},{"key":"3612_CR57","doi-asserted-by":"publisher","first-page":"457","DOI":"10.5301\/tj.5000672","volume":"103","author":"L Fariselli","year":"2017","unstructured":"Fariselli L, Cuppini L, Gaviani P et al (2017) Short course radiotherapy concomitant with temozolomide in GBM patients: a phase II study. Tumori 103:457\u2013463. https:\/\/doi.org\/10.5301\/tj.5000672","journal-title":"Tumori"},{"key":"3612_CR58","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1200\/JCO.2005.04.6979","volume":"24","author":"JC Buckner","year":"2006","unstructured":"Buckner JC, Ballman KV, Michalak JC et al (2006) Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93\u201372-52 and Southwest Oncology Group 9503 Trials. J Clin Oncol 24:3871\u20133879. https:\/\/doi.org\/10.1200\/JCO.2005.04.6979","journal-title":"J Clin Oncol"},{"key":"3612_CR59","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ijrobp.2012.01.020","volume":"84","author":"DB Einstein","year":"2012","unstructured":"Einstein DB, Wessels B, Bangert B et al (2012) Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 84:668\u2013674. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.01.020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl","key":"3612_CR60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3171\/sup.2006.105.7.139","volume":"105","author":"DS Kong","year":"2006","unstructured":"Kong DS, Nam D-H, Lee J-I et al (2006) Preservation of quality of life by preradiotherapy stereotactic radiosurgery for unresectable glioblastoma multiforme. J Neurosurg 105(Suppl):139\u2013143. https:\/\/doi.org\/10.3171\/sup.2006.105.7.139","journal-title":"J Neurosurg"},{"key":"3612_CR61","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.ijrobp.2006.02.042","volume":"65","author":"R Cardinale","year":"2006","unstructured":"Cardinale R, Won M, Choucair A et al (2006) A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. Intl J Radiat Oncol Biol Phys 65:1422\u20131428. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.02.042","journal-title":"Intl J Radiat Oncol Biol Phys"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03612-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-020-03612-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-020-03612-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T17:56:37Z","timestamp":1605808597000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-020-03612-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["3612"],"URL":"https:\/\/doi.org\/10.1007\/s11060-020-03612-7","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"11 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Mateo Ziu: None; Betty Y Kim: None; Wen Jiang: None; Timothy C. Ryken: None; Jeffrey J. Olson: American Cancer Society, Editorial Consultant. The Update on Newly Diagnosed Glioblastoma Task Force members were required to report all possible COIs prior to beginning work on the guideline, using the COI disclosure form of the AANS\/CNS Joint Guidelines Committee, including potential COIs that are unrelated to the topic of the guideline. The CNS Guidelines Committee and Guideline Task Force Chair reviewed the disclosures and either approved or disapproved the nomination. The CNS Guidelines Committee and Guideline Task Force Chair are given latitude to approve nominations of Task Force Members with possible conflicts and address this by restricting the writing and reviewing privileges of that person to topics unrelated to the possible COIs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"These guidelines were funded exclusively by the CNS Guidelines Committee and the AANS\/CNS Joint Tumor Section Executive Committee with no funding from any outside commercial sources to support the development of this document.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}